Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Koo

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
CNS Drugs|June 16, 2026
Managing Dermatologic Delusional Disorders: A US Psychodermatology Perspective for CliniciansAndrea Leung, John Koo
Journal of Drugs in Dermatology : JDD|August 12, 2009
The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparisonChai Sue Lee, John Koo
Dermatologic Clinics|August 23, 2005
Psychopharmacologic therapies in dermatology: an updateChai Sue Lee, John Koo
Clinics in Dermatology|December 19, 2012
Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatristKelly Kyunghwa Park, John Koo
The Journal of Dermatological Treatment|October 2, 2018
Atopic dermatitis spectrum disorder: new conceptualization for the coming new therapeutic eraDaniel C Butler, John Koo
Cutis|October 17, 2008
A practical review and update on the management of pruritus sine materiaMelanie J Tuerk, John Koo
Journal of Drugs in Dermatology : JDD|October 19, 2007
Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporineZahida Khan Maskatia, John Koo
Case Reports in Infectious Diseases|October 12, 2018
A Rare Case of <i>Burkholderia cepacia</i> Complex Septic ArthritisJohn Koo, Gregory D Deans
JAMA Dermatology|August 27, 2020
Special Consideration for Patients With Morgellons Disease, Even Among Psychodermatology Patients?Nicholas D Brownstone, John Koo
Cutis|March 2, 2021
Recent developments in psychodermatology and psychopharmacology for delusional patientsNicholas D Brownstone, John Koo
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
CNS Drugs|June 16, 2026
Managing Dermatologic Delusional Disorders: A US Psychodermatology Perspective for CliniciansAndrea Leung, John Koo
Journal of Drugs in Dermatology : JDD|August 12, 2009
The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparisonChai Sue Lee, John Koo
Dermatologic Clinics|August 23, 2005
Psychopharmacologic therapies in dermatology: an updateChai Sue Lee, John Koo
Clinics in Dermatology|December 19, 2012
Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatristKelly Kyunghwa Park, John Koo
The Journal of Dermatological Treatment|October 2, 2018
Atopic dermatitis spectrum disorder: new conceptualization for the coming new therapeutic eraDaniel C Butler, John Koo
Cutis|October 17, 2008
A practical review and update on the management of pruritus sine materiaMelanie J Tuerk, John Koo
Journal of Drugs in Dermatology : JDD|October 19, 2007
Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporineZahida Khan Maskatia, John Koo
Case Reports in Infectious Diseases|October 12, 2018
A Rare Case of <i>Burkholderia cepacia</i> Complex Septic ArthritisJohn Koo, Gregory D Deans
JAMA Dermatology|August 27, 2020
Special Consideration for Patients With Morgellons Disease, Even Among Psychodermatology Patients?Nicholas D Brownstone, John Koo
Cutis|March 2, 2021
Recent developments in psychodermatology and psychopharmacology for delusional patientsNicholas D Brownstone, John Koo
Pageof 22